COMP <GO>
SNWV vs ABBV // GROSS PROFIT MARGIN
SANUWAVE Health Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: SNWV 7
— ABBV 4
▲ GROSS PROFIT MARGIN LEADER: SNWV
LAST: $5.27 (0.00%) • MKT CAP: $45.3M
gross-margins
77.10%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNWV VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNWV | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 77.10% | 70.20% | +6.90 | SNWV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 67.30% | 29.00% | +38.30 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.5x | 33.3x | -25.80 | SNWV | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 3.47% | +0.80 | SNWV | /fcf-yield <GO> |
| Operating Margin | 11.20% | 24.60% | -13.40 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 26.80% | 6.90% | +19.90 | SNWV | /net-margins <GO> |
| Revenue Growth (YoY) | 36.30% | 8.60% | +27.70 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.33 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.4 | 65.1 | -14.74 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.5x | 113.1x | -109.60 | SNWV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.3M | $513.86B | -$513.81B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNWV REV | ABBV REV | SNWV GROSS % | ABBV GROSS % | SNWV FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.1M | $61.16B | 77.1% | 70.2% | $1.9M | $17.82B |
| FY 2024 | $32.3M | $56.33B | 75.9% | 70.0% | $2.0M | $17.83B |
| FY 2023 | $19.3M | $54.32B | — | — | -$4.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNWV // BETA —
ABBV // BETA 1.15